• Extensive expertise in the application of chemical and oligonucleotide tools to cell-based (2D/3D/Co- Culture) and organotypic platforms for: o Target-Identification & Validation, o Dissecting Mechanisms-of-Action o Drug Discovery o Screening and Lead-Optimization (establishing Structure-Activity Relationships) • Significant knowledge of: o Molecular biology o Cell biology o In vitro pharmacology o Cancer biology (oncogenic drivers and signaling networks)
• Methods of different staining, immunofluorescence, immunohistochemistry • Protein biochemical analysis techniques such as protein extraction, SDS-PAGE and western blotting • Various molecular biology techniques such as DNA/RNA isolation, PCR and qPCR techniques, microarrays, cloning, DNA sequencing, recombinant DNA technology and gene knockout • Animal cell lines: passaging, cryoconservation
Shaving Products, nutritional and cosmetic products, over the counter (OTC) medications, medical devices, FDA Approvals, clinical study evaluations, Product Portfolio Strategy Development, New Product Development (NPD), female athletic apparel products, Organizational Leadership and Product Management
• Research and development of tissue engineering • Medical devices research and development • Orthopedic and Medical Devices materials market analysis • Investigational studies to develop preventive therapies to minimize the progression of post-traumatic osteoarthritis. • Implementation of preclinical animal studies on bone morphogenetic protein-2 dosing and calcium phosphate coatings for treatment of maxillofacial and long segmental bone defects.
GHB Intellect has been providing IP technical and business consulting services since 2007, including turn-key IP assessments, development, management, valuation, and monetization support. Our goal is to align our client’s IP portfolio development and monetization activities with their business objectives.